| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/24/2023 | 176.24% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 06/05/2023 | 176.24% | HC Wainwright & Co. | $18 → $15 | Maintains | Buy |
| 04/14/2023 | 231.49% | HC Wainwright & Co. | $3 → $18 | Maintains | Buy |
| 08/26/2022 | -44.75% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 01/03/2022 | 10.5% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
| 06/01/2021 | 28.91% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 05/11/2021 | -17.13% | Lake Street | → $4.5 | Initiates Coverage On | → Buy |
| 02/09/2021 | 10.5% | HC Wainwright & Co. | $8 → $6 | Maintains | Buy |
| 11/30/2020 | 84.16% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 08/17/2020 | 120.99% | HC Wainwright & Co. | $14 → $12 | Maintains | Buy |
What is the target price for Arcadia Biosciences (RKDA)?
The latest price target for Arcadia Biosciences (NASDAQ: RKDA) was reported by HC Wainwright & Co. on July 24, 2023. The analyst firm set a price target for $15.00 expecting RKDA to rise to within 12 months (a possible 176.24% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Arcadia Biosciences (RKDA)?
The latest analyst rating for Arcadia Biosciences (NASDAQ: RKDA) was provided by HC Wainwright & Co., and Arcadia Biosciences reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Arcadia Biosciences (RKDA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcadia Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcadia Biosciences was filed on July 24, 2023 so you should expect the next rating to be made available sometime around July 24, 2024.
Is the Analyst Rating Arcadia Biosciences (RKDA) correct?
While ratings are subjective and will change, the latest Arcadia Biosciences (RKDA) rating was a reiterated with a price target of $0.00 to $15.00. The current price Arcadia Biosciences (RKDA) is trading at is $5.43, which is within the analyst's predicted range.